| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019514910-A |
| titleOfInvention |
Quinazoline derivative or salt thereof and pharmaceutical composition containing the same |
| abstract |
The present invention provides quinazoline derivatives or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions comprising them and their uses. The quinazoline derivative or a pharmaceutically acceptable salt thereof has selective inhibitory activity on the .delta. Subunit of phosphatidylinositol 3-kinase and thus avoids the side effects such as the inflammatory response associated with lymphopenia Can be usefully applied to the prevention or treatment of cancer. |
| priorityDate |
2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |